OBI Pharma, Inc.

OBI Pharma, Inc.

Uses your system voice; voice and rate in settings.

≈ 1 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

OBI Pharma, Inc. ( ) ( ) is a bio-pharmaceutical company, based in Nangang District, Taipei, Taiwan. In 2018 it announced that its drug, OBI-3424, has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of Hepatocellular Carcinoma (HCC).

References

Optimer Pharmaceuticals

Text derived from https://en.wikipedia.org/w/index.php?oldid=1359628412 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001359628412 · captured 2026-06-16 · ledger · version history

Cite this page as: encyclopegia.org, “OBI Pharma, Inc.”, snapshot enwiki-001359628412. https://encyclopegia.org/a/obi-pharma-inc

Sources cited in this revision

16 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.